comparemela.com

Latest Breaking News On - மெய்நிகர் சுகாதாரம் மாநாடு - Page 9 : comparemela.com

Investegate |INVENTIVA Announcements | INVENTIVA: 2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States

Investegate |INVENTIVA Announcements | INVENTIVA: 2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

INVENTIVA: 2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States

INVENTIVA: 2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

Black Diamond Therapeutics to Present at Upcoming Investor Conferences CAMBRIDGE, Mass. and NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update about the Company’s progress at the following upcoming investor conferences: The Cowen 41 st Annual Virtual Health Care Conference. Dr. Epstein will be featured in a lung cancer panel session on Tuesday, March 2, 2021 at 11:10 AM ET. The session will be available via live webcast to conference attendees.

Investegate |INVENTIVA Announcements | INVENTIVA: Full-Year 2020: Cash position and revenues

Important Notice This press release contains forward-looking statements, forecasts and estimates with respect to Inventiva’s clinical trials, clinical trial data releases, clinical development plans and anticipated future activities of Inventiva. Certain of these statements, forecasts and estimates can be recognized by the use of words such as, without limitation, “believes”, “anticipates”, “expects”, “intends”, “plans”, “seeks”, “estimates”, “may”, “will” and “continue” and similar expressions. Such statements are not historical facts but rather are statements of future expectations and other forward-looking statements that are based on management s beliefs. These statements reflect such views and assumptions prevailing as of the date of the statements and involve known and unknown risks and uncertainties that could cause future results, performance or future events to differ materially from those expressed or implied in such statements. Ac

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.